Literature DB >> 25663204

Trends in the frequency of original research in acne vulgaris, rosacea, dermatitis, psoriasis, skin cancer, and skin infections, 1970-2010.

Young M Choi1, Jashin J Wu2.   

Abstract

CONTEXT: Medical journals have allowed researchers to share their latest discoveries, especially in the most common diseases affecting patients worldwide.
OBJECTIVE: To analyze trends in the frequency of original research into common dermatologic diseases from 1970 to 2010.
DESIGN: A retrospective review of the Journal of the American Academy of Dermatology and the Archives of Dermatology was performed using the MEDLINE database. All original research articles published between 1970 and 2010, by quinquennium, dealing with acne vulgaris, rosacea, skin cancer, dermatitis, psoriasis, or skin infections were included. MAIN OUTCOME MEASURE: Total number of publications dealing with each dermatologic topic considered.
RESULTS: The frequency of research into acne vulgaris and rosacea decreased from 24% in 1970 to 5.1% in 2010. Psoriasis research increased in frequency from 17.6% to 26.5% from 2000 to 2010, and skin cancer research increased from 4% in 1970 to 48% in 2010.
CONCLUSIONS: Topics that experienced early advancements in research, such as acne vulgaris and rosacea, demonstrated a decreasing trend in the frequency of publication. Published psoriasis research has increased in frequency since 2000, most likely because of the discovery of biologics. Finally, skin cancer research has continued to increase in frequency of publication, paralleling the increasing incidence of skin cancer.

Entities:  

Mesh:

Year:  2015        PMID: 25663204      PMCID: PMC4315376          DOI: 10.7812/TPP/14-104

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  23 in total

Review 1.  Rosacea: I. Etiology, pathogenesis, and subtype classification.

Authors:  Glen H Crawford; Michelle T Pelle; William D James
Journal:  J Am Acad Dermatol       Date:  2004-09       Impact factor: 11.527

Review 2.  Dermatologists and office-based care of dermatologic disease in the 21st century.

Authors:  Robert S Stern
Journal:  J Investig Dermatol Symp Proc       Date:  2004-03

3.  For research grants, 2005 budget request may be signpost of future declines.

Authors:  Stacye Bruckbauer
Journal:  J Natl Cancer Inst       Date:  2004-03-03       Impact factor: 13.506

4.  Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study.

Authors:  Kenneth B Gordon; Richard G Langley; Craig Leonardi; Darryl Toth; M Alan Menter; Sewon Kang; Michael Heffernan; Bruce Miller; Regina Hamlin; Liberata Lim; Jianhua Zhong; Rebecca Hoffman; Martin M Okun
Journal:  J Am Acad Dermatol       Date:  2006-08-10       Impact factor: 11.527

5.  Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys.

Authors:  M Innes Asher; Stephen Montefort; Bengt Björkstén; Christopher K W Lai; David P Strachan; Stephan K Weiland; Hywel Williams
Journal:  Lancet       Date:  2006-08-26       Impact factor: 79.321

6.  Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.

Authors:  U Chaudhari; P Romano; L D Mulcahy; L T Dooley; D G Baker; A B Gottlieb
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

7.  Trends in incidence of adult-onset psoriasis over three decades: a population-based study.

Authors:  Murat Icen; Cynthia S Crowson; Marian T McEvoy; Frank J Dann; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  J Am Acad Dermatol       Date:  2009-03       Impact factor: 11.527

Review 8.  New visions for atopic eczema: an iPAC summary and future trends.

Authors:  Fabienne Rancé; Mark Boguniewicz; Susanne Lau
Journal:  Pediatr Allergy Immunol       Date:  2008-08       Impact factor: 6.377

Review 9.  Rosacea: II. Therapy.

Authors:  Michelle T Pelle; Glen H Crawford; William D James
Journal:  J Am Acad Dermatol       Date:  2004-10       Impact factor: 11.527

10.  Etanercept as monotherapy in patients with psoriasis.

Authors:  Craig L Leonardi; Jerold L Powers; Robert T Matheson; Bernard S Goffe; Ralph Zitnik; Andrea Wang; Alice B Gottlieb
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.